scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M309381200 |
P953 | full work available at URL | http://www.jbc.org/article/S0021925820755730/pdf |
https://api.elsevier.com/content/article/PII:S0021925820755730?httpAccept=text/plain | ||
https://api.elsevier.com/content/article/PII:S0021925820755730?httpAccept=text/xml | ||
https://syndication.highwire.org/content/doi/10.1074/jbc.M309381200 | ||
P3181 | OpenCitations bibliographic resource ID | 4865509 |
P698 | PubMed publication ID | 14517219 |
P2093 | author name string | John C. Reed | |
Chao-Zhou Ni | |||
Chenglong Li | |||
Edelmira Cabezas | |||
Carl F. Ware | |||
Kathryn R. Ely | |||
Arnold C. Satterthwait | |||
Marnie L. Havert | |||
Paula S. Norris | |||
Elizabeth M. Chiong | |||
Bonnie R. Tran | |||
P2860 | cites work | The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells | Q22254033 |
Downstream regulator TANK binds to the CD40 recognition site on TRAF3 | Q24297105 | ||
Distinct molecular mechanism for initiating TRAF6 signalling | Q24302174 | ||
A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 | Q24306620 | ||
Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 | ||
A lymphotoxin-beta-specific receptor | Q24312186 | ||
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction | Q24313173 | ||
Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB | Q24564927 | ||
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein | Q24599252 | ||
Molecular basis for CD40 signaling mediated by TRAF3 | Q24656208 | ||
Crystallographic analysis of CD40 recognition and signaling by human TRAF2 | Q24675068 | ||
Improved methods for building protein models in electron density maps and the location of errors in these models | Q26776980 | ||
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
Structural basis for self-association and receptor recognition of human TRAF2 | Q27617947 | ||
The structural basis for the recognition of diverse receptor sequences by TRAF2 | Q27619945 | ||
Convergent solutions to binding at a protein-protein interface | Q27621452 | ||
MOLMOL: a program for display and analysis of macromolecular structures | Q27860873 | ||
The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction | Q27938967 | ||
The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor | Q28255713 | ||
TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor | Q28282051 | ||
The CD40 antigen and its ligand | Q28286277 | ||
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
Unraveling hot spots in binding interfaces: progress and challenges | Q29614463 | ||
Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines | Q34381306 | ||
Signaling by CD40 and its mimics in B cell activation | Q34397107 | ||
Human TNF receptor-associated factor 5 (TRAF5): cDNA cloning, expression and assignment of the TRAF5 gene to chromosome 1q32. | Q34428280 | ||
Structurally adaptive hot spots at a protein interaction interface on TRAF3. | Q35007303 | ||
Death and survival: viral regulation of TNF signaling pathways | Q35031970 | ||
The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways | Q40696432 | ||
How B and T cells talk to each other | Q40714365 | ||
Immune regulation by CD40 and its ligand GP39. | Q41039754 | ||
Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways | Q41728935 | ||
Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. | Q44130049 | ||
Energetic determinants of internal motif recognition by PDZ domains | Q46062615 | ||
TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation | Q48064873 | ||
Side-chain flexibility in proteins upon ligand binding. | Q52080522 | ||
Crystallization and preliminary X-ray analysis of the TRAF domain of TRAF3 | Q74506495 | ||
P433 | issue | 50 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biochemistry | Q7094 |
cell biology | Q7141 | ||
signal transduction | Q828130 | ||
signal transducing adaptor protein | Q5964993 | ||
P304 | page(s) | 50523-9 | |
P577 | publication date | 2003-09-29 | |
2003-12-12 | |||
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling | |
Structurally Distinct Recognition Motifs in Lymphotoxin-β Receptor and CD40 for Tumor Necrosis Factor Receptor-associated Factor (TRAF)-mediated Signaling | |||
P478 | volume | 278 |
Q37026428 | A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1. |
Q33883378 | Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor |
Q35925874 | Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily |
Q28474495 | Beauty is in the eye of the beholder: proteins can recognize binding sites of homologous proteins in more than one way |
Q38919438 | Comparison of the peptide binding preferences of three closely related TRAF paralogs: TRAF2, TRAF3, and TRAF5 |
Q35946248 | Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes. |
Q27680632 | Dimerization of LT R by LT 1 2 is necessary and sufficient for signal transduction |
Q24294565 | Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases |
Q37678950 | Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma. |
Q37314736 | Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma |
Q37948116 | How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members? |
Q90575916 | Immunochip meta-analysis in European and Argentinian populations identifies two novel genetic loci associated with celiac disease |
Q38960255 | Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor |
Q33725721 | Inference of surface membrane factors of HIV-1 infection through functional interaction networks |
Q45436282 | LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. |
Q36918115 | Molecular basis of NF-κB signaling |
Q52337490 | Negative Regulation of Interferon-β Production by Alternative Splicing of Tumor Necrosis Factor Receptor-Associated Factor 3 in Ducks. |
Q33849388 | Oncogenic activation of NF-kappaB. |
Q35634096 | Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes |
Q27023925 | Roles of TRAF3 in T cells: many surprises |
Q39814540 | Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1 |
Q27675124 | Single Amino Acid Substitutions Confer the Antiviral Activity of the TRAF3 Adaptor Protein onto TRAF5 |
Q27649432 | Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome |
Q63915433 | T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword |
Q36572388 | TRAF family member-associated NF-kappa B activator (TANK) expression increases in injured sensory neurons and is transcriptionally regulated by Sox11. |
Q33707599 | TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling |
Q50792035 | TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. |
Q38840587 | TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry. |
Q37132817 | TRAF4, at the Crossroad between Morphogenesis and Cancer |
Q37036159 | Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways |
Q24314976 | The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation |